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Abstract
An inflammatory process has been involved in numerous neurodegenerative disorders such as Parkinson’s disease,
stroke and Alzheimer’s disease (AD). In AD, the inflammatory response is mainly located in the vicinity of amyloid
plaques. Cytokines, such as interleukin-8 (IL-8) and interleukin-1 (IL-1), have been clearly involved in this inflam-
matory process. Polymorphisms of several interleukin genes have been correlated to the risk of developing AD. The
present study investigated the association of AD with polymorphisms IL-8 -251T > A (rs4073) and IL-1-889C > T
(rs1800587) and the interactive effect of both, adjusted by the Apolipoprotein E genotype. 199 blood samples from
patients with AD, 146 healthy elderly controls and 95 healthy young controls were obtained. DNA samples were iso-
lated from blood cells, and the PCR-RFLP method was used for genotyping. The genotype distributions of
polymorphisms IL-8, IL-1 and APOE were as expected under Hardy-Weinberg equilibrium. The allele frequencies
did not differ significantly among the three groups tested. As expected, the APOE4 allele was strongly associated
with AD (p < 0.001). No association of AD with either the IL-1 or the IL-8 polymorphism was observed, nor was any
interactive effect between both polymorphisms. These results confirm previous studies in other populations, in which
polymorphisms IL-8 -251T > A and IL-1-889C > T were not found to be risk factors for AD.
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Introduction
Alzheimer disease (AD) is a progressive neuro-
degenerative disorder that causes loss of memory, mental
confusion and several cognitive disturbances. It frequently
occurs at around 60 years of age, but may also have an early
onset at 40 years (Khachaturian, 1985). Dementia is an in-
creasingly common diagnosis in the aging population, and
the numbers are expected to rise exponentially in coming
years. AD alone affects 5 million people in the US, while
millions more are currently affected by vascular dementia,
Lewy body disease and frontotemporal dementia
(Grossman et al., 2006).
Two neuropathological features characterize the AD
brain: amyloid plaques and neurofibrillary tangles. Plaques
are mostly characterized by extracellular deposits of amy-
loid- peptide (A), which is derived from the processing
of the amyloid precursor protein (APP). Neurofibrillary
tangles correspond to intracellular accumulation of fibrils
called paired helical filaments (Cacquevel et al., 2004). In
this sense, the neurological implications of AD come from
the coexistence of two degenerative processes, tau protein
aggregation and A deposition, that affect polymodal asso-
ciation brain areas, a feature never observed in non-human
primates and difficult to model (Delacourte, 2006).
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Familial early-onset AD is associated with mutations
in the APP and presenilin genes, whereas only a polymor-
phic variation at the apolipoprotein E (APOE) locus, the  4
allelic form has so far been firmly established as a genetic
risk factor for late-onset familial and sporadic AD. How-
ever, these genetic risk factors only account for about 30-50
percent of all cases of AD. Thus, an interaction between ge-
netic, biological and environmental factors might account
for most AD cases, by promoting inflammatory reactions,
particularly those mediated by the release of interleukin-1
(IL-1) from microglial cells of the brain (Hayes et al.,
2004).
Infection or injury of the body results in inflamma-
tion. A hallmark of this response is the recruitment of neu-
trophils from the blood to the injured tissue. This process
could be directed by chemotactic polypeptides, the so-
called chemokines (Zlotnik and Yoshie, 2000). Chemo-
kines are low-molecular-weight chemotactic cytokines that
have been shown to play an important role in early inflam-
matory events (Baggiolini et al., 1994). So far, microglial
cells were shown to display an increased migratory re-
sponse to  chemokines, including monocyte chemotactic
protein 1 (MCP-1), suggesting that these molecules may
play an important role in the trafficking of mononuclear
phagocytes within the brain (Peterson et al., 1997). It is
widely accepted that chronic inflammatory reaction plays
an important role in the pathogenesis of AD, and a variety
of inflammatory factors, including cytokines and chemo-
kines, have been detected in and around plaques and tangles
(Galimberti et al., 2006; Pomponi et al., 2008). Moreover,
elevated levels of chemokines are demonstrable in the brain
in neurodegenerative diseases, such as AD, whereas in
healthy brains they are detected at low levels (Galimberti et
al., 2006). Thirumangalakudi et al. (2008) made an im-
munohistochemical analysis of activated microglia and
astrocytes as neuroinflammation markers, cytokines ex-
pression and cognitive alteration in C57/BL6 and low-
-density lipoprotein receptor (LDLR) (-/-)-deficient mice
fed a fat/cholesterol-rich diet. Their findings link hypercho-
lesterolemia with cognitive dysfunction potentially medi-
ated by increased neuroinflammation and APP processing
in a non-transgenic mouse model.
IL-8 enhances the survival of hippocampal neurons in
vitro and increases the proliferation of glial cells (Araujo
and Cotman, 1993). Strong immunoreactivity for CXCR2
(chemokine (C-X-C motif) receptor 2), the IL-8-related re-
ceptor, has been demonstrated in both AD and age-matched
subjects with non-inflammatory affections of the nervous
system. In particular, CXCR2 expression in AD is close to
neuritic plaques, surrounding A deposits (Galimberti et
al., 2003, 2006). Increased IL-1 expression, in the form of
higher tissue concentrations of the IL-1 protein and in-
creased numbers of IL-1 immunoreactive astrocytes, has
been demonstrated in the brains of patients with AD and in
those elderly individuals with Down syndrome who show
AD-type pathology in their brains (Griffin et al., 1989).
Polymorphisms located in the promoter regions of the
IL-1 and IL-8 genes have been widely studied as risk fac-
tors for AD. For instance, the IL-1-889C > T polymor-
phism was strongly associated with late-onset AD in
samples from two different centers: Indianapolis, IN, USA,
and Munich, Germany (Du et al., 2000). However, other
studies conducted in different populations did not show this
association (Kuo et al., 2003; Tang et al., 2004; Zhou et al.,
2006; Dursun et al., 2009; Hu et al., 2009). In addition, In-
fante et al. (2004) reported that neither the presence of the
IL-1-889 T allele nor the presence of the IL-8 -251T > A
polymorphism TT genotype was associated with AD in
Caucasians originating from a homogeneous population in
a limited geographical area in Northern Spain. However,
subjects carrying both the IL-1A allele T and the IL-8 TT
genotype had about twice the risk of developing AD than
subjects without these genotypes.
In the present study, we characterized the IL-8 -251T
> A and IL-1-889C > T polymorphisms in AD patients,
healthy young and elderly control groups. We also investi-
gated a possible interactive effect between these polymor-
phisms in the developing of AD, as proposed by Infante et
al. (2004)
Materials and Methods
Patients and controls
Peripheral blood samples were obtained from 440
Brazilian individuals: 199 AD patients, 146 healthy elderly
controls (EC) and 95 healthy young controls (YC).
The sample of AD patients was composed of 87.44%
subjects of European origin, 6.80% of Japanese origin and
5.76% of African origin; the sample of elderly controls was
composed of 89.78% subjects of European origin, 5.84% of
Japanese origin and 4.38% of African origin; and the sam-
ple of young controls was composed of 87.65% subjects of
European origin, 6.8% of Japanese origin and 4.75% of Af-
rican origin. Thus, there was no difference in the ethnic dis-
tribution of the three groups. The mean age and standard
deviation of the samples was: 73.81  7.95 years in the AD
group, composed of 68 men and 131 women; 71.25  9.02
years in the EC group, composed of 53 men and 93 women;
and 20.56  1.64 years in the YC group, composed of 31
men and 64 women. The AD patients were selected accord-
ing to the NINCDS-ADRDA criteria for probable AD
(McKhann et al., 1984). Vascular dementia was excluded
by a Hachinski score of 5 or higher and by neuro-imaging
(Hachinski et al., 1975). Patients as well as controls were
from São Paulo City, and all subjects gave informed con-
sent for participation in this study, which was approved by
the USC (Universidade do Sagrado Coração de Bauru) eth-
ics committee (Protocol number 0110/2004). The control
groups were composed of relatives (spouse or children) or
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friends of the patients. For these groups, exclusion criteria
were a history and examination findings suggestive of neu-
rological (seizure, brain trauma with loss of consciousness
longer than 15 min, stroke, Parkinson’s disease) or psychi-
atric disease (depression and substance abuse, including al-
cohol), and evidence of functional decline as shown by a
structured questionnaire. All experiments were conducted
in accordance with the Declaration of Helsinki.
Laboratory analysis
Total genomic DNA was extracted from blood sam-
ples using a Qiagen extraction kit, according to the manu-
facturer’s instructions.
IL-8 -251T > A genotyping: IL-8 -251T > A geno-
types were determined using the polymerase chain reaction
restriction fragment length polymorphism (PCR-RFLP)
method. A 349 bp fragment was amplified from genomic
DNA using the forward and reverse oligonucleotides
IL-8F1 5’-CAT GAT AGC ATC TGT AAT TAA CTG-3’
and IL-8R2 5’-CTC ATC TTT TCA TTA TGT CAG AG-
3’, respectively, as described previously (Hamajima et al.,
2003). PCR conditions involved an initial denaturation step
of 94 °C/5 min, followed by 30 cycles of 94 °C for 45 s,
52 °C for 45 s, 72 °C for1 min, and a final extension step of
72 °C for 7 min. The amplification products were digested
with MunI restriction enzyme (Fermentas, Ottawa, ON,
Canada), subjected to electrophoresis on a 3% agarose gel,
stained with ethidium bromide and analyzed on an Alpha
Imager 2200 (Alpha Innotech Corporation, San Leandro,
CA, USA). After digestion, three different band combina-
tions were found, viz. a 349 bp fragment (TT genotype),
202 and 147 bp fragments (AA genotype); and 349, 202 and
147 bp fragments (TA genotype).
IL-1-889C > T genotyping: IL1-889C > T geno-
types were also determined using PCR- RFLP. A 194 bp
fragment was amplified from genomic DNA using the for-
ward and reverse oligonucleotides IL-1AF1 5’-GCA TGC
CAT CAC ACC TAG TT-3’ and IL-1AR1 5’-TTA CAT
ATG AGC CTT CCA TG-3’, respectively, as described
previously (Tanriverdi et al., 2006). The PCR conditions
included an initial denaturation step of 94 °C for 5 min, fol-
lowed by 40 cycles of 94 °C for 30 s, 55 °C for 30 s, 72 °C
for 30 s, and a final extension step of 72 °C for 7 min. The
amplification products were digested with NcoI (Fermen-
tas, Ottawa, ON, Canada), subjected to electrophoresis on a
3% agarose gel, stained with ethidium bromide and ana-
lyzed on an Alpha Imager 2200 (Alpha Innotech Corpora-
tion, San Leandro, CA, USA). After digestion, again three
different results were found: a 194 bp fragment (TT geno-
type); 174 and 20 bp fragments (CC genotype); and 194,
174 and 20 bp fragments (TC genotype). The 20 bp frag-
ments could not be visualized in the agarose gel.
APOE genotyping: The APOE genotypes were deter-
mined by PCR-RFLP using the oligonucleotides and reac-
tion conditions described by Hixson and Vernier (1990).
The amplification products were digested with HhaI (Fer-
mentas, Ottawa, ON, Canada), subjected to electrophoresis
on a 4% NuSieve® GTG® agarose gel (Cambrex, Rockland,
ME, USA), stained with ethidium bromide and analyzed on
an Alpha Imager 2000 (Alpha Innotech Corporation, San
Leandro, CA, USA).
Statistical analysis
The chi-square test was used to compare categorical
variables and to test the deviation from the Hardy-Wein-
berg equilibrium for each polymorphism. A value of
p < 0.05 was considered statistically significant, and all
tests were two-tailed. Logistic regression was used to in-
vestigate the individual relationships and interactive effect
between independent variables (carriers versus non-car-
riers of the IL-1 T allele, and carriers versus non-carriers
of the IL-8 TT genotype). This approach was based on the
findings of Infante et al. (2004), who suggested an interac-
tive effect of the IL-1A allele and the IL-8 TT genotype. For
this analysis, we considered both polymorphisms as de-
pendent variables, and gender, age and APOE genotype
groups as co-variables in the model. The crude odds ratio
(OR) was calculated considering the AD group genotypes
in relation to the genotypes of the elderly and of the young
control groups, using gender and age as co-variables. The
adjusted odds ratio (OR) by APOE genotype considered
three groups of APOE genotypes: 1) E2E2 with E2E3; 2)
E3E3; and 3) E3E4 with E4E4, as well as gender and age as
co-variables. Ninety-five percent confidence intervals were
calculated. The statistical analyses were performed using
the SPSS 16.0 package.
Results
Table 1 presents the IL-8 -251T > A and IL1-889C >
T genotype distributions in the AD, EC and YC subject
groups. The APOE genotype distributions among the three
subject groups are also shown in Table 1. There were no
statistically significant differences concerning gender
among the subject groups (p = 0.22; data not shown).
The genotype distributions concerning the IL-8 -251T
> A and the IL-1-889C > T polymorphism were in Hardy-
Weinberg equilibrium in all three subject groups. The APOE
genotype distribution was also in Hardy-Weinberg equilib-
rium in the three subject groups. The comparison of the ge-
notype frequency distribution in the AD patients and the EC
group did not show any significant difference for either IL-8
- 251T > A (p = 0.05) or IL-1 -889C > T (p = 0.23). Simi-
larly, no significant difference was found in the comparison
between AD patients and the YC group (Table 1).
Logistic regression analysis did not detect an associa-
tion of AD with any of the polymorphisms individually. An
interactive effect of both polymorphisms in our tri-hybrid
Brazilian population was not detected (Tables 1 and 2). As
expected, logistic regression analysis revealed a strong as-
Polymorphisms in Alzheimer's disease 3
sociation of the E4 allele in AD patients in relation to the
EC (OR = 8.137, 95% CI = 4.569-14.489, p < 0.001) and
YC (OR = 3.174, 95% CI = 1.850-5.446, p < 0.001) groups
(data not shown).
Discussion
This study was the first one to investigate a potential
association of polymorphisms IL-8 -251T > A and IL-1-
889C > T with AD in a Brazilian population. The genotype
distributions of polymorphisms IL-8, IL-1 and APOE in
the three subject groups were in Hardy-Weinberg equilib-
rium. We did not observe an association of IL-8 -251T > A
and/or IL-1-889C > T with AD. The findings concerning
IL-8 -251T > A confirmed our previous study with a
smaller sample (Vendramini et al., 2007), which did not de-
tect an association of this polymorphism with AD either.
Infante et al. (2004) also observed a lack of association of
polymorphisms IL-1-889C > T and IL-8 -251T > A with
AD. No association of the IL1-A polymorphism with AD
was also reported in Chinese samples from Taiwan (Kuo et
al., 2003), from the Chengdu area (Tang et al., 2004), and
in a Han population (Hu et al., 2009). Similarly, the IL-1-
889C > T polymorphism was not associated with AD either
in individuals from the Canary Islands, Spain (Deniz-Na-
ranjo et al., 2008) or in a homogeneous Caucasoid popula-
tion from northern Spain (Infante et al., 2004).
No interactive effect of the IL-1-889T allele and the
IL-8 TT genotype concerning the AD group in relation to
EC and YC was detected (Tables 1 and 2). However, our
findings differed from those of Infante et al. (2004). This
discrepancy may be due to the distinct ethnic composition
of both populations. As it is well known, the Brazilian pop-
ulation is mainly composed of European, African and Am-
erindian descendants. Other variables, such as the AD age
of onset or another undetectable stratification bias may also
be involved.
Our findings concerning the lack of association of IL8
and IL1 with AD and of an interactive effect between them
were consistent with the great majority of reports from dif-
ferent population samples. Hence, taking together our re-
sults with others from the literature, it appears that IL-8
-251T > A and IL-1-889C > T do not play a major role in
the pathogenesis of late-onset AD.
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Table 2 - Odds ratio (OR) - crude and adjusted by APOE genotype – and 95% confidence interval (CI) for interaction between IL-1 T allele and IL-8 TT
genotype obtained from logistic regression analysis concerning Alzheimer’s disease (AD) and elderly controls (EC), and Alzheimer’s disease (AD) and
young controls (YC).
IL-1 T allele IL-8 TT genotype AD (%) EC (%) OR(95%CI) p* OR(95%CI) p**
- - 35.70 33.60 1 (reference) 1 (reference)
- + 12.60 19.90 0.595 (0.312-1.136) 0.12 0.542 (0.277-1.060) 0.07
+ - 38.70 28.80 1.265 (0.750-2.135) 0.38 1.110 (0.639-1.926) 0.71
+ + 13.10 17.80 0.690 (0.359-1.328) 0.27 0.553 (0.278-1.097) 0.09
IL-1 T allele IL-8 TT genotype AD (%) YC (%) OR(95%CI) p* OR(95%CI) p**
- - 35.70 42.10 1 (reference) 1 (reference)
- + 12.60 18.90 0.782 (0.381-1.606) 0.50 0.666 (0.317-1.401) 0.28
+ - 38.70 29.50 1.549 (0.867-2.769) 0.14 1.345 (0.737-2.455) 0.33
+ + 13.10 9.50 1.628 (0.695-3.813) 0.26 1.174 (0.486-2.838) 0.72
*Crude OR. **Adjusted by APOE genotypes.
Table 1 - Absolute and relative genotype frequencies of the IL-8 and
IL-1 polymorphisms and APOE genotypes in an Alzheimer’s disease pa-
tient group (AD) and in an elderly (EC) and a young (YC) healthy control
groups.
IL-8 -251T > A* AD EC YC
A/A 47 (23.62%) 28 (19.18%) 19 (20%)
T/A 101 (50.75%) 63 (43.15%) 49 (51.8%)
T/T 51 (25.63%) 55 (37.67%) 27 (28.42%)
IL-1-889C > T**
C/C 96 (48.24%) 78 (53.42%) 58 (61.05%)
T/C 84 (42.21%) 61 (41.78%) 30 (31.58%)
T/T 19 (9.55%) 7 (4.79%) 7 (7.37%)
APOE genotype
E2/E2 0 (0%) 1 (0.68%) 1 (1.05%)
E2/E3 11 (5.53%) 11 (7.53%) 15 (15.79%)
E3/E3 85 (42.71%) 117 (80.14%) 55 (57.89%)
E2/E4 7 (3.52%) 2 (1.38%) 1 (1.05%)
E3/E4 78 (39.20%) 14 (9.59%) 20 (21.05%)
E4/E4 18 (9.04%) 1 (0.68%) 3 (3.17%)
Total 199 (100%) 146 (100%) 95 (100%)
*Chi-square test p value for AD x EC = 0.056; for AD x YC = 0.751.
**Chi-square test p value for AD x EC = 0.226; for AD x YC = 0.120.
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